Caveolin-deficient mice: insights into caveolar function and human disease

被引：182

作者：

Razani, B

Lisanti, MP

机构：

[1] Albert Einstein Coll Med, Albert Einstein Comprehens Canc Ctr, Dept Mol Pharmacol, Bronx, NY 10461 USA

[2] Albert Einstein Coll Med, Albert Einstein Comprehens Canc Ctr, Div Hormone Dependent Tumor Biol, Bronx, NY 10461 USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2001年 / 108卷 / 11期

关键词：

D O I：

10.1172/JCI14611

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：1553 / 1561

页数：9

共 45 条

[1] Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease [J].

Betz, RC ;

Schoser, BGH ;

Kasper, D ;

Ricker, K ;

Ramírez, A ;

Stein, V ;

Torbergsen, T ;

Lee, YA ;

Nöthen, MM ;

Wienker, TF ;

Malin, JP ;

Propping, P ;

Reis, A ;

Mortier, W ;

Jentsch, TJ ;

Vorgerd, M ;

Kubisch, C .

NATURE GENETICS, 2001, 28 (03) :218-219

[2] In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation [J].

Bucci, M ;

Gratton, JP ;

Rudic, RD ;

Acevedo, L ;

Roviezzo, F ;

Cirino, G ;

Sessa, WC .

NATURE MEDICINE, 2000, 6 (12) :1362-1367

[3] Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia [J].

Carbone, I ;

Bruno, C ;

Sotgia, F ;

Bado, M ;

Broda, P ;

Masetti, E ;

Panella, A ;

Zara, F ;

Bricarelli, FD ;

Cordone, G ;

Lisanti, MP ;

Minetti, C .

NEUROLOGY, 2000, 54 (06) :1373-1376

[4] Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice [J].

Drab, M ;

Verkade, P ;

Elger, M ;

Kasper, M ;

Lohn, M ;

Lauterbach, B ;

Menne, J ;

Lindschau, C ;

Mende, F ;

Luft, FC ;

Schedl, A ;

Haller, H ;

Kurzchalia, TV .

SCIENCE, 2001, 293 (5539) :2449-2452

[5] Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth [J].

Engelman, JA ;

Wykoff, CC ;

Yasuhara, S ;

Song, KS ;

Okamoto, T ;

Lisanti, MP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16374-16381

[6] Cholesterol and caveolae: structural and functional relationships [J].

Fielding, CJ ;

Fielding, PE .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1529 (1-3) :210-222

[7] Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation -: Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutants and rescues wild-type caveolin-3 [J].

Galbiati, F ;

Volonté, D ;

Minetti, C ;

Bregman, DB ;

Lisanti, MP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :37702-37711

[8] Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts -: Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation [J].

Galbiati, F ;

Volonté, D ;

Engelman, JA ;

Scherer, PE ;

Lisanti, MP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30315-30321

[9] Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities [J].

Galbiati, F ;

Engelman, JA ;

Volonte, D ;

Zhang, XL ;

Minetti, C ;

Li, MM ;

Hou, H ;

Kneitz, B ;

Edelmann, W ;

Lisanti, MP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :21425-21433

[10] Emerging themes in lipid rafts and caveolae [J].

Galbiati, F ;

Razani, B ;

Lisanti, MP .

CELL, 2001, 106 (04) :403-411

← 1 2 3 4 5 →